(MEOH) Methanex - Ratings and Ratios
Exchange: NASDAQ • Country: Canada • Currency: USD • Type: Common Stock • ISIN: CA59151K1084
MEOH: Methanol, Chemicals, Petrochemicals
Methanex Corporation is a leading global producer and supplier of methanol, a critical commodity in the chemicals and energy sectors. With operations spanning China, Europe, the United States, South America, South Korea, Canada, and Asia, Methanex leverages its extensive geographic presence to ensure a reliable supply chain. This strategic reach is complemented by their role as a purchaser of methanol from third parties, both through offtake contracts and spot market transactions.
The companys operational efficiency is bolstered by its ownership and leasing of storage and terminal facilities, which are crucial for maintaining logistics control and reducing transportation costs. Additionally, Methanex manages a fleet of approximately 30 ocean-going vessels, enhancing their ability to manage global distribution effectively. This vertical integration underscores their commitment to operational reliability and cost management.
As one of the largest methanol producers, Methanex holds a significant position in the industry, supported by over five decades of experience since its incorporation in 1968. Headquartered in Vancouver, Canada, the companys strategic locations and global supply chain network contribute to its competitive edge, ensuring stability and efficiency in serving its clients in the chemical and petrochemical sectors.
From a financial standpoint, Methanex boasts a market capitalization of approximately $3.4 billion, reflecting its substantial presence in the market. The current P/E ratio of 21.29 indicates a premium valuation, while the forward P/E of 11.59 suggests anticipated growth. The P/B ratio of 1.64 and a P/S ratio of 0.93 highlight the companys valuation relative to its book value and revenue generation efficiency, respectively. These metrics provide insights into Methanexs financial health and growth prospects for investors and fund managers.
Additional Sources for MEOH Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
MEOH Stock Overview
Market Cap in USD | 2,865m |
Sector | Basic Materials |
Industry | Chemicals |
GiC Sub-Industry | Commodity Chemicals |
IPO / Inception | 1992-05-19 |
MEOH Stock Ratings
Growth 5y | 55.1% |
Fundamental | -8.83% |
Dividend | 63.4% |
Rel. Strength Industry | -8.7 |
Analysts | 4.2/5 |
Fair Price Momentum | 35.92 USD |
Fair Price DCF | 148.48 USD |
MEOH Dividends
Dividend Yield 12m | 1.78% |
Yield on Cost 5y | 6.21% |
Annual Growth 5y | 9.41% |
Payout Consistency | 93.8% |
MEOH Growth Ratios
Growth Correlation 3m | -42.6% |
Growth Correlation 12m | -19.8% |
Growth Correlation 5y | 66.5% |
CAGR 5y | 25.28% |
CAGR/Max DD 5y | 0.52 |
Sharpe Ratio 12m | 0.52 |
Alpha | -21.42 |
Beta | 0.91 |
Volatility | 58.82% |
Current Volume | 266.4k |
Average Volume 20d | 375.6k |
As of March 14, 2025, the stock is trading at USD 36.78 with a total of 266,400 shares traded.
Over the past week, the price has changed by -11.84%, over one month by -20.97%, over three months by -19.23% and over the past year by -13.53%.
Neither. Based on ValueRay Fundamental Analyses, Methanex is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -8.83 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MEOH as of March 2025 is 35.92. This means that MEOH is currently overvalued and has a potential downside of -2.34%.
Methanex has received a consensus analysts rating of 4.20. Therefor, it is recommend to buy MEOH.
- Strong Buy: 4
- Buy: 4
- Hold: 2
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, MEOH Methanex will be worth about 39.1 in March 2026. The stock is currently trading at 36.78. This means that the stock has a potential upside of +6.33%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 63.4 | 72.4% |
Analysts Target Price | 57.9 | 57.4% |
ValueRay Target Price | 39.1 | 6.3% |